Diabetes Medical Nutrition Therapy in Southeastern African American Women
- Conditions
- Type 2 Diabetes
- Interventions
- Behavioral: Diabetes MNTBehavioral: Motivational Interviewing
- Registration Number
- NCT04971889
- Lead Sponsor
- Meharry Medical College
- Brief Summary
A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 291
- African American
- Female
- Clinical diagnosis of type 2 diabetes for at least 6 months
- At risk for development and/or progression of diabetes complications (HbA1c ≥ 7.0% AND either systolic blood pressure ≥130, LDL cholesterol ≥ 100, or BMI ≥ 30).
--Observed or diagnosed psychotic disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Diabetes MNT plus MI Motivational Interviewing --Group-based dietary/dietary motivation intervention Diabetes MNT plus MI Diabetes MNT --Group-based dietary/dietary motivation intervention Diabetes MNT Diabetes MNT -Group-based dietary intervention
- Primary Outcome Measures
Name Time Method HbA1c Baseline Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Change from Baseline HbA1c 12 months Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
- Secondary Outcome Measures
Name Time Method LDL Cholesterol Baseline Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Systolic Blood Pressure Baseline A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Body Mass Index Baseline Calculated measure of body max index from height/weight measures
Change from baseline LDL Cholesterol 12 months Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Change from Baseline Body Mass Index 12 months Calculated measure of body max index from height/weight measures
Change from baseline Systolic Blood Pressure 12 months A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Trial Locations
- Locations (2)
Meharry Medical College
🇺🇸Nashville, Tennessee, United States
Matthew Walker Comprehensive Health Center
🇺🇸Nashville, Tennessee, United States